MCL1 and hepatocellular carcinoma: In addition, we presented a novel strategy to enhance the efficacy of MLN2238 in HCC via modulation of Mcl-1 activity by pharmacological inhibition, using the small molecule Mcl-1 inhibitor A1210477.